Literature DB >> 12401963

Transferrin regulates transcription of the MBP gene and its action synergizes with IGF-1 to enhance myelinogenesis in the md rat.

A Espinosa-Jeffrey1, S Kumar, P M Zhao, O Awosika, C Agbo, A Huang, R Chang, J De Vellis.   

Abstract

Myelin-deficient (md) rats and their unaffected littermates were injected at postnatal day 4 either with a single dose of transferrin (Tf) or insulin-like growth factor one (IGF-1) singly or combined. Two weeks later, their brains were perfused and coronal sections were analyzed for MBP by in situ hybridization and for transferrin and myelin basic protein (Tf and MBP) by double immunofluorescence. Each of the factors separately had an effect on mutant animals as seen by both increased OL maturation, and MBP mRNA and protein synthesis. The combination of factors resulted in a profound enhancement of the myelinogenic properties of oligodendrocytes (OL) with a consequent increase in the number of MBP-labeled fibers. The brains of unaffected littermates also responded to growth factor(s) injection either by increasing myelination in some brain areas or by regulating the synthesis of MBP in OL. Using rat OL cultures we studied the site of transferrin action for the expression of MBP gene. We found by run off transcription that the MBP mRNA was significantly increased at the nuclear level but the PLP message was unaffected. Thus, transferrin selectively regulates MBP at the transcriptional level and together with IGF-1 synergizes to increase both the maturation and myelinogenic properties of md and normal OL. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12401963     DOI: 10.1159/000065698

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  16 in total

1.  Proof-of Concept that an Acute Trophic Factors Intervention After Spinal Cord Injury Provides an Adequate Niche for Neuroprotection, Recruitment of Nestin-Expressing Progenitors and Regeneration.

Authors:  Warin Krityakiarana; Paul M Zhao; Kevin Nguyen; Fernando Gomez-Pinilla; Naiphinich Kotchabhakdi; Jean de Vellis; Araceli Espinosa-Jeffrey
Journal:  Neurochem Res       Date:  2016-02-17       Impact factor: 3.996

Review 2.  Pathogenic implications of iron accumulation in multiple sclerosis.

Authors:  Rachel Williams; Cassandra L Buchheit; Nancy E J Berman; Steven M LeVine
Journal:  J Neurochem       Date:  2011-11-11       Impact factor: 5.372

3.  Expression of transcripts for myelin related genes in postmortem brain from cocaine abusers.

Authors:  Lars V Kristiansen; Michael J Bannon; James H Meador-Woodruff
Journal:  Neurochem Res       Date:  2008-03-21       Impact factor: 3.996

Review 4.  Intranasal Insulin and Insulin-Like Growth Factor 1 as Neuroprotectants in Acute Ischemic Stroke.

Authors:  Vasileios-Arsenios Lioutas; Freddy Alfaro-Martinez; Francisco Bedoya; Chen-Chih Chung; Daniela A Pimentel; Vera Novak
Journal:  Transl Stroke Res       Date:  2015-06-05       Impact factor: 6.829

5.  Nutritional factors and aging in demyelinating diseases.

Authors:  Ana M Adamo
Journal:  Genes Nutr       Date:  2013-12-06       Impact factor: 5.523

6.  SIRT1 is essential for normal cognitive function and synaptic plasticity.

Authors:  Shaday Michán; Ying Li; Maggie Meng-Hsiu Chou; Edoardo Parrella; Huanying Ge; Jeffrey M Long; Joanne S Allard; Kaitlyn Lewis; Marshall Miller; Wei Xu; Ronald F Mervis; Jing Chen; Karen I Guerin; Lois E H Smith; Michael W McBurney; David A Sinclair; Michel Baudry; Rafael de Cabo; Valter D Longo
Journal:  J Neurosci       Date:  2010-07-21       Impact factor: 6.167

7.  Apotransferrin-induced recovery after hypoxic/ischaemic injury on myelination.

Authors:  Mariano Guardia Clausi; Laura A Pasquini; Eduardo F Soto; Juana M Pasquini
Journal:  ASN Neuro       Date:  2010-11-19       Impact factor: 4.146

Review 8.  The insulin-like growth factor (IGF) receptor type 1 (IGF1R) as an essential component of the signalling network regulating neurogenesis.

Authors:  Alexander Annenkov
Journal:  Mol Neurobiol       Date:  2009-08-29       Impact factor: 5.590

9.  Sensitivity and specificity of decreased CSF asialotransferrin for eIF2B-related disorder.

Authors:  A Vanderver; Y Hathout; J Maletkovic; E S Gordon; M Mintz; M Timmons; E P Hoffman; L Horzinski; F Niel; A Fogli; O Boespflug-Tanguy; R Schiffmann
Journal:  Neurology       Date:  2008-06-03       Impact factor: 9.910

10.  Longitudinal CSF Iron Pathway Proteins in Posthemorrhagic Hydrocephalus: Associations with Ventricle Size and Neurodevelopmental Outcomes.

Authors:  Jennifer M Strahle; Kelly B Mahaney; Diego M Morales; Chandana Buddhala; Chevis N Shannon; John C Wellons; Abhaya V Kulkarni; Hailey Jensen; Ron W Reeder; Richard Holubkov; Jay K Riva-Cambrin; William E Whitehead; Curtis J Rozzelle; Mandeep Tamber; Ian F Pollack; Robert P Naftel; John R W Kestle; David D Limbrick
Journal:  Ann Neurol       Date:  2021-06-25       Impact factor: 11.274

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.